Chercheuse en santé publique, Responsable pédagogique Master 2 Santé Internationale


2005. PhD Sociology – Public Health. Institut de Santé Publique, d’Epidémiologie et de Développement (ISPED), Université Bordeaux Segalen, Bordeaux

2001. Masters in Public Health – Research. Institut Santé Développement, Université Paris 6 – Pierre et Marie Curie, Paris

2001. Masters in Public Health – Professional. ISPED, Université Bordeaux Segalen, Bordeaux

1999. MSc Geography, Université Paris 4 – Sorbonne, Paris


  • January 2017 to date.

Co-Primary investigator, ANRS 12371 Multi-Morbidity study. Inserm/Africa Health Research Institute.

Formative research study aiming at developing an integrated model for multi-morbidity testing and management in rural South Africa

  • July 2010 to date.

Co-investigator and project coordinator, ANRS 12249 TasP trial. Inserm/Africa Centre for Health and Population Studies.

Randomised controlled trial evaluating the effect of ART initiated immediately after HIV diagnosis, irrespective of CD4 count criteria, on the reduction in incidence of new HIV infections in the general population in KwaZulu Natal (South Africa).



  • March 2006-December 2012.

Co-investigator and project coordinator, ANRS 12127 Prenahtest trial. ISPED, Université Victor Segalen Bordeaux 2 .

Randomised intervention trial: evaluation of the feasibility and impact of couple-oriented post-test HIV counselling on partner HIV counselling and testing, couple communication and sexual and reproductive health and HIV prevention behaviours, in four low to medium HIV prevalence countries (Cameroon, India, Dominican Republic, Georgia).

  • April 2003-October 2004.

Project coordinator, HIV/AIDS programme. Service de Coopération et d’Action Culturelle, Ambassade de France au Zimbabwe (Harare).

Fonds de Solidarité Prioritaire (FSP) 2002-40 on the prevention of mother-to-child transmission of HIV (PMTCT) in rural Zimbabwe.

  • January 2001-March 2003.

Research assistant. ISPED, Université Victor Segalen Bordeaux 2, Bordeaux.

Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) projects (CTA# 28-01, 79-01 and 80-01) on PMTCT implementation in Zimbabwe.



  • Perriat D, Balzer L, Hayes R, (..), Orne-Gliemann J, Dabis F. Comparative assessment of five trials of universal HIV testing and treatment in sub-Saharan Africa. J Int AIDS Soc 2018; 21(1).
  • Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. The Lancet HIV 2017.
  • Tiendrebeogo T, Plazy M, Darak S, (..), Orne-Gliemann J. Couples HIV counselling and couple relationships in India, Georgia and the Dominican Republic. BMC Public Health 2017; 17(1): 901.
  • Plazy M, Perriat D, Gumede D, (..), Orne-Gliemann J. Implementing universal HIV treatment in a high HIV prevalence and rural South African setting – Field experiences and recommendations of health care providers. PLoS One 2017; 12(11): e0186883.
  • Foster G, Orne-Gliemann J, Font H, et al. The impact of facility-based mother support groups on retention in care and PMTCT outcomes in rural Zimbabwe: the EPAZ cluster-randomised controlled trial. JAIDS 2017; 75(Suppl 2): S207-15.
  • Orne-Gliemann J, Font H, Maphosa T, et al. Patterns of attendance at Mother Support Groups in Zimbabwe. The EPAZ trial (2014-2016). JAIDS 2017; 75(Suppl 2): S216-S23.
  • Iwuji CC, Orne-Gliemann J, Larmarange J, et al. Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial. PLoS Med. 2016;13(8):e1002107.
  • Camlin CS, Seeley J, Viljoen L, Venooij E, Simwinga M, Reynolds R, Reis R, Plank R, Orne-Gliemann J, McGrath N Larmarange J, Hoddinoo G, Getahin M, Charlebois E, Bond V. Strengthening universal HIV ‘test-and-treat’ approaches with social science research. AIDS 2016;30:969-70.
  • Plazy M, Farouki KE, Iwuji C, Okesola N, Orne-Gliemann J, et al. Access to HIV care in the context of universal test and treat: challenges within the ANRS 12249 TasP cluster-randomized trial in rural South Africa. J Int AIDS Soc. 2016;19(1):20913.
  • Orne-Gliemann J, Zuma T, Chikovore J, et al. Community perceptions of repeat HIV-testing: experiences of the ANRS 12249 Treatment as Prevention trial in rural South Africa. AIDS Care. 2016;28 Suppl 3:14-23.
  • Chikovore J, Gillespie N, McGrath N, Orne-Gliemann J, Zuma T. Men, masculinity, and engagement with treatment as prevention in KwaZulu-Natal, South Africa. AIDS Care. 2016;28 Suppl 3:74-82.
  • Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Barnighausen T, et al. Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal. BMC public health. 2015;15:209.
  • Burgos-Soto J, Orne-Gliemann J, Encrenaz G, Patassi A, Woronowski A, Kariyiare B, et al. Intimate partner sexual and physical violence among women in Togo, West Africa: prevalence, associated factors, and the specific role of HIV infection. Global health action. 2014;7:23456.
  • Butsashvili M, Kajaia M, Kamkamidze G, Tchendjou P, Desgrées du Lou A, Dabis F, Orne-Gliemann J. Factors Associated with HIV Testing History among Pregnant Women and Their Partners in Georgia: The ANRS 12127 Prenahtest Trial. AIDS Res Treat 2014;2014:356090.
  • Darak S, Gadgil M, Balestre E, Kulkarni M, Kulkarni V, Kulkarni S, Orne-Gliemann J; the ANRS 12127 Prenahtest Study Group. HIV risk perception among pregnant women in western India: Need for reducing vulnerabilities rather than improving knowledge! AIDS Care. 2014;26(6):709-15
  • Orne-Gliemann J, Balestre E, Tchendjou P, Miric M, Darak S, Butsashvili M, Perez-Then E, Eboko F, Plazy M, Kulkarni S, Loû AD, Dabis F; for the Prenahtest ANRS 12127 Study Group. Increasing HIV testing among male partners. AIDS. 2013; Apr 24;27(7):1167-77.
Département de recherche santé publique Université de Bordeaux logo_ISPED logo_INRIA logo_HONcode